Y08060
CAS No. 2222565-19-5
Y08060 ( Y 08060 )
Catalog No. M13549 CAS No. 2222565-19-5
Y08060 is a potent and selective BET inhibitor with Kd of 306 nM for BRD4 BD1.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
Size | Price / USD | Stock | Quantity |
100MG | Get Quote | Get Quote |
|
200MG | Get Quote | Get Quote |
|
500MG | Get Quote | Get Quote |
|
1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameY08060
-
NoteResearch use only, not for human use.
-
Brief DescriptionY08060 is a potent and selective BET inhibitor with Kd of 306 nM for BRD4 BD1.
-
DescriptionY08060 is a potent and selective BET inhibitor with Kd of 306 nM for BRD4 BD1, displays excellent selectivity for BET subfamily over other non-BET family with the exception of moderate inhibition of CBP/EP300; esuppresses cell growth, colony formation, and expression of androgen receptor (AR), AR regulated genes, and MYC in prostate cancer cell lines. such as C4-2B, LNCaP, and 22Rv1; demonstrates good PK profile with high oral bioavailability (61.54%).
-
SynonymsY 08060
-
PathwayChromatin/Epigenetic
-
TargetBromodomain
-
RecptorBromodomain
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number2222565-19-5
-
Formula Weight471.32
-
Molecular FormulaC18H19BrN2O6S
-
Purity>98% (HPLC)
-
Solubility——
-
SMILES——
-
Chemical Name5-bromo-2-methoxy-N-(6-methoxy-2,2-dimethyl-3-oxo-3,4-dihydro-2H-benzo[b][1,4]oxazin-7-yl)benzenesulfonamide
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Xiang Q, et al. ACS Med Chem Lett. 2018 Feb 13;9(3):262-267.
molnova catalog
related products
-
GSK1324726A
A potent and selective inhibitor of BET bromodomain with IC50 of 41 nM/31 nM/22 nM for BRD2/BRD3/BRD4 respectively.
-
Olinone
Olinone is a selective inhibitor for the BET BRD1 with Kd of 3.4/3.7/8.6 uM for BRD4-BrD1/BRD3-BrD1/BRD2-BrD1, respectively.
-
L-45
PCAF BRD inhibitor L-45 is a potent, selective, and cell-active PCAF bromodomain inhibitor with Ki of 47 nM in HTRF assays.